Pd. Ling et al., THE EPSTEIN-BARR-VIRUS IMMORTALIZING PROTEIN EBNA-2 IS TARGETED TO DNA BY A CELLULAR ENHANCER-BINDING PROTEIN, Proceedings of the National Academy of Sciences of the United Statesof America, 90(20), 1993, pp. 9237-9241
The Epstein-Barr virus nuclear antigen EBNA-2 is essential for Epstein
-Barr virus-induced immortalization of B cells. EBNA-2 is a transcript
ional activator capable of modifying the expression of specific viral
and cellular genes. However, the mechanism of EBNA-2 transactivation h
as been an enigma. We used a fractionated extract of CA46 lymphoblasto
id cells and bacterially expressed EBNA-2 polypeptides to demonstrate
that EBNA-2 is targeted to the Epstein-Barr virus latency C promoter (
Cp) through interaction with a cellular DNA binding protein designated
Cp binding factor 1 (CBF1). A glutathione S-transferase-EBNA-2 fusion
protein containing aa 252-425 of EBNA-2 interacted with CBF1 to yield
a slowly migrating complex in an electrophoretic mobility shift assay
. Mutation of EBNA-2 aa 323 and 324, which lie within a highly conserv
ed amino acid motif, abolished the interaction with CBF1. This same mu
tation also abolished the ability of EBNA-2 to activate the Cp in a co
transfection assay. The binding site for CBF1 was localized to residue
s -359 to -388 of the Cp by using an electrophoretic mobility shift as
say and DNase I footprinting. Introduction of multiple copies of the C
BF1 binding site upstream of a minimal heterologous promoter conferred
EBNA-2 responsiveness on that promoter. Mutation of a core sequence C
NGTGGGAA abolished CBF1 binding, and the mutated sequence was unable t
o mediate EBNA-2 transactivation. The CBF1 core sequence also occurs i
n other EBNA-2-responsive promoters suggesting that CBF1 may mediate E
BNA-2 transactivation of both cellular and viral targets.